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Letter to the Editor
HEPATOCELLULAR CARCINOMA, HEPATITIS B AND MEASLES
SIR-Primary hepatocellular carcinoma
(PHC) is a common malignant tumour of
sub-Saharan Africa (Leading article, 1970).
Evidence ofhepatitis B infection (either HBs
antigenaemia at the time of diagnosis, or the
presence ofantibody to HBc or HBs) is found
significantly more frequently in PCH patients
than in controls (Larouze et al., 1976). Per-
sistence ofHepatitis B may be associated with
an inadequate cellular immune response
(Dudley et al., 1972) as a result of which
chronic hepatitis, cirrhosis and PHC may de-
velop. The transition, however, from an HBv-
infected liver through these stages to PHC
has not been described in Africa. A biological
marker which indicates whether patients with
HBs-associated PHC had passed through
these stages would be of considerable clinical
and epidemiological importance.
Measles is a widespread disease in Africa
with a significant morbidity, often occurring
at a younger age than in Western countries
(Morley 1969) Triger and colleagues. (Triger
et (li., 1972) demonstrated the presence of
a highly significant increase in high-titre
measles and rubella antibodies in patients
Awith chronic active hepatitis, but no clinical
evidence of recent measles. Laitinen &
Vaheri (1974), in a study of measles and
rubella antibodies in the sera of 12,269
patients, found 30 with very high titres, 15
of whom were suffering from acute or chronic
liver disease. This present study aimed to see
Nwhether patients with HBs-associated PHC
had measles-antibody levels greater than
normal controls, as a possible marker of
previous chronic liver disease.
Measles-antibody titres in 16 African adults
with proved HBs+ PHC were compared with
16 normal African adults wrho were HBs-.
Measles antibody wasmeasured byanenzyme-
linked immunosorbent assay (ELISA)
method; 3 negative controls were also in-
cluded. At the end ofthe ELISA reaction, the
absorbance of the contents of each well wAas
measured sphectrophotometrically at 400 nm,
and the results of the 2 groups compared.
There wiere 5 females in the PHC group,
and 8 in the controls. The ages of the PHC
patients wiere not accurately known, though
none was less than about 20 years. The ab-
sorbance values for the 2 groups, and the 3
negative controls, are shown in the Figure.
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Fiac. Distribution of measles antibody
(measured by ELISA method) in 16
patients with PHC who were HBs+ (*),
16 normal Hbs- (]) andl 3 negative con-
trols (E).
The mtean absorbance of the PHC group was
0 62 (s.e. 0.09), compared to 0 75 (s.e. 0.05)
for the controls, an insignificant difference.
In this study, 4/16 PHC patients had no
serological evidence of past measles, and in
none of the PHC patients Nere very high
levels of antibody detected. Measles-antibody
levels cannot therefore be used as a biological
marker of preceding chronic hepatitis in the
genesis of PHC. It may be that, following
resolution of activity in chronic hepatitis,
measles-antibody levels return to normal; or,
in these African patients, chronic hepatitis is
not associated with high measles-antibody
levels; or, since cirrhosis may be found in up
to 65% of West African PHC patients (Payet
& Sankale, 1971), the aetiology of the
cirrhosis does not lie in a preceding chronic
hepatitis, butina moredirectlyenvironmental
insult such as mycotoxins.
G. H. REE
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I am grateful to Dr A. Voller ofthe London School
of Hygiene and Tropical Medicine for performing
the measles ELISA tests.
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